BREAKING
- FDA issues authorization for first molecular non-prescription, at-home COVID-19 test
- River Blindness in the Americas, Lymphatic Filariasis and Malaria on Hispaniola elimination effort: Carter Center’s new partnership
- Influenza vaccine: Flucelvax Quadrivalent approved for people two years of age and older
- Brazil COVID-19 variant, P.1, reported in Chicago
- Philippines reports more COVID variants, Vaccines arrive in country